| |
|
|
|
Hemispherx Biopharma Inc.  
|
|
1.93 0.008 (0%) |
08-23 16:00 |
|
Open: |
1.9 |
Pre close: |
1.9223 |
Target:
|
3.67 
|
|
High: |
2.06 |
Low: |
1.8965 |
Resistance:
|
3.14
4.04
|
|
Volume: |
57,868 |
Market Cap: |
4M |
Support:
|
1.69
1.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.92
 |
MACD |
MACD(12,26):
|
-0.40 |
|
MA(20): |
2.08 |
Signal(12,26,9): |
-0.48 |
|
MA(100): |
4.80 |
Stochastic Oscillator |
%K(14,3):
|
28.65 |
|
MA(250): |
7.54 |
%D(3): |
25.83 |
|
Average Volume(K) |
3-Month: |
17711
|
52-Week |
High:
|
14.96 |
|
10-Days: |
5523 |
Low: |
1.69 |
|
RSI |
RSI(14):
|
26.60 |
Change(%): |
-83.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-7.706 |
Return on Equity (ttm) |
-128.9 |
Shares Out. (M) |
0.25 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-50.0 |
Shares Float (M) |
2.00 |
|
EPS Est. Next Year |
-0.030 |
PEG Ratio |
-0.01 |
% Held by Insiders |
12.78 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-12.1 |
% Held by Institutions |
6.09 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
-2.056 |
Shares Short (K) |
145 |
|
Book Value (p.s.) |
2.400 |
EBITDA (p.s.) |
-43.859 |
P/E |
-0.25 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.80 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.63 |
P/S |
2110329.00 |
|
Operating Margin |
-3846.25 |
Levered Free Cash Flow
(M) |
-6.46 |
P/CF |
-0.05 |
|
|
|
|
|
|
